Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02319837 · OUTCOME

Overall Survival (OS)

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) · Source last updated 2026-07-09

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
From randomization until death due to any cause (up to Month 98 when at least 197 MFS events occurred among the 3 treatment groups)

What was measured

Overall survival was defined as the time in months between randomization and death due to any cause.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2027-09
denom Units Selected
Participants
description
Overall survival was defined as the time in months between randomization and death due to any cause.
reporting Status
NOT_POSTED
time Frame
From randomization until death due to any cause (up to Month 98 when at least 197 MFS events occurred among the 3 treatment groups)
title
Overall Survival (OS)
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice